LAS VEGAS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, ...

The SKYWARD programme includes two planned prospective, multi-centre, single-arm IDE studies.

Shockwave Medical, Inc. SWAV recently announced the full U.S. commercial availability of the Shockwave L6 Peripheral Intravascular Lithotripsy (IVL) Catheter. This follows the receipt of the FDA’s ...

When Johnson & Johnson paid $13.1 billion to acquire Shockwave Medical in 2024, it wasn't just buying a company—it was betting on the future of IVL, a technology that has rapidly transformed how ...

SANTA CLARA, CALIF., April 27, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified ...

J&J is working to expand use of Shockwave’s technology as competition in intravascular lithotripsy builds from companies like Boston Scientific and Stryker.

Johnson & Johnson has announced the European launch of its Shockwave Javelin Peripheral IVL Catheter, an intravascular lithotripsy (IVL) platform aimed at addressing calcium buildup in severely ...

Johnson & Johnson shocked the medtech industry early last year when it announced it would acquire Shockwave Medical, a specialist in the intravascular lithotripsy (IVL) market. Shockwave had a huge ...